Signaturefd, LLC Pacira Bio Sciences, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 85 shares of PCRX stock, worth $1,654. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 97 12.37%

Holding current value

$1,654

Previous $2,000 50.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$11.7 - $28.46 $140 - $341	-12 Reduced 12.37%	85 $1,000
Q2 2024 Jul 29, 2024	SELL	$25.5 - $31.51 $6,553 - $8,098	-257 Reduced 72.6%	97 $2,000
Q1 2024 May 03, 2024	BUY	$27.7 - $35.48 $193 - $248	7 Added 2.02%	354 $10,000
Q4 2023 Jan 31, 2024	BUY	$26.32 - $34.31 $8,238 - $10,739	313 Added 920.59%	347 $11,000
Q3 2023 Nov 03, 2023	SELL	$30.68 - $40.09 $613 - $801	-20 Reduced 37.04%	34 $1,000
Q2 2023 Aug 01, 2023	SELL	$36.12 - $47.5 $16,253 - $21,375	-450 Reduced 89.29%	54 $2,000
Q1 2023 Apr 28, 2023	BUY	$35.53 - $43.38 $15,597 - $19,043	439 Added 675.38%	504 $20,000
Q4 2022 Jan 27, 2023	SELL	$38.19 - $57.45 $649 - $976	-17 Reduced 20.73%	65 $2,000
Q3 2022 Nov 08, 2022	BUY	$51.24 - $58.89 $922 - $1,060	18 Added 28.13%	82 $4,000
Q2 2022 Aug 10, 2022	BUY	$51.49 - $81.64 $1,699 - $2,694	33 Added 106.45%	64 $4,000
Q4 2020 Feb 11, 2021	SELL	$50.47 - $66.26 $403 - $530	-8 Reduced 20.51%	31 $2,000
Q3 2020 Nov 03, 2020	BUY	$51.97 - $63.0 $415 - $504	8 Added 25.81%	39 $2,000
Q2 2020 Jul 30, 2020	BUY	$30.8 - $52.47 $954 - $1,626	31 New	31 $2,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account